These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36417351)

  • 1. Improving prescribing: a feasibility study of pharmacogenetic testing with clinical decision support in primary healthcare in Singapore.
    Smith H; Dawes M; Katzov-Eckert H; Burrell S; Xin Hui S; Winther MD
    Fam Pract; 2022 Nov; ():. PubMed ID: 36417351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study.
    Dawes M; Aloise MN; Ang JS; Cullis P; Dawes D; Fraser R; Liknaitzky G; Paterson A; Stanley P; Suarez-Gonzalez A; Katzov-Eckert H
    CMAJ Open; 2016; 4(3):E528-E534. PubMed ID: 27730116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
    Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
    Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priorities for family physician and general practitioner recruitment and retention in Singapore: a PRIORITIZE study.
    Tudor Car L; Teng YS; How JW; Nazri NNBM; Tan ALX; Quah J; Peckham S; Smith H
    BMC Fam Pract; 2021 Nov; 22(1):229. PubMed ID: 34784892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.
    Danahey K; Borden BA; Furner B; Yukman P; Hussain S; Saner D; Volchenboum SL; Ratain MJ; O'Donnell PH
    J Biomed Inform; 2017 Nov; 75():110-121. PubMed ID: 28963061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
    Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
    JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
    Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
    JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
    Bank PCD; Swen JJ; Guchelaar HJ
    BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative study of challenges and enablers faced by private general practitioners providing primary care to patients with complex needs in Singapore.
    Wong PYA; Chan FYS; Ong L; Lee KH
    BMC Prim Care; 2022 Jan; 23(1):14. PubMed ID: 35172750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis.
    Anderson JD; Davis BH; Giang G; Jones A; Lee CR; Parker K; Searcy H; Benner K; Limdi NA; Guimbellot JS
    Clin Transl Sci; 2023 Apr; 16(4):662-672. PubMed ID: 36760155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' and physicians' perspectives on pharmacogenetic testing.
    Rogausch A; Prause D; Schallenberg A; Brockmöller J; Himmel W
    Pharmacogenomics; 2006 Jan; 7(1):49-59. PubMed ID: 16354124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of evidence-based knowledge in general practice.
    Le JV
    Dan Med J; 2017 Dec; 64(12):. PubMed ID: 29206099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived facilitators and barriers to chronic disease management in primary care networks of Singapore: a qualitative study.
    Foo C; Surendran S; Tam CH; Ho E; Matchar DB; Car J; Koh GCH
    BMJ Open; 2021 May; 11(5):e046010. PubMed ID: 33947737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding role of pharmacogenomics in the management of cardiovascular disorders.
    Yip VL; Pirmohamed M
    Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing cardiovascular disease prevention guidelines to translate evidence-based medicine and shared decision making into general practice: theory-based intervention development, qualitative piloting and quantitative feasibility.
    Bonner C; Fajardo MA; Doust J; McCaffery K; Trevena L
    Implement Sci; 2019 Aug; 14(1):86. PubMed ID: 31466526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.
    Bradley P; Shiekh M; Mehra V; Vrbicky K; Layle S; Olson MC; Maciel A; Cullors A; Garces JA; Lukowiak AA
    J Psychiatr Res; 2018 Jan; 96():100-107. PubMed ID: 28992526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.